INDV: Indivior Group Earnings per share for the last twelve months

Official company branding of Indivior Corp (INDV)

Indivior PLC (INDV) is expanding its presence in addiction clinics, which supports its performance dynamics. However, geopolitical logistics disruptions and patent disputes are creating pressure. The 12-month rolling specific income metric clearly demonstrates these fluctuations, and the current value is 3.59, reflecting the balance between profitability and regulatory risks.

INDV (Indivior PLC) Net earnings per share for the last four quarters history from 02/21/2024 to 11/12/2026

Financial and market metric breakdowns for Indivior plc (INDV)

- current quotes and average value forecast:
Price Chart Indivior PLC|INDV - Fair Value Consensus
- market capitalization information:
Market Value Indivior PLC|INDV - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Indivior|INDV - Book Valuation of Business|Market Value to Book Value Ratio indivior.com|INDV - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Indivior PLC|INDV - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Indivior Group|INDV - Company Total Debt Obligations|Debt to Book Value Indivior PLC|INDV - Company Long-Term Debt|Company Short-Term Debts Indivior|Quick Liquidity indivior.com
- net income and valuation multiples indicators:
INDV - Company Net Income|Expected Profit Indivior PLC|INDV - Company Value to Net Income|Projected Price to Earnings Indivior|INDV - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indivior PLC|INDV - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months Indivior|INDV - Earnings per share for the last twelve months|Quarterly EPS earnings growth indivior.com|INDV - Net earnings per share growth this year|Earnings growth forecast for next year Indivior PLC
Fundamental company analysis:Indivior PLC - INDV
Manufactured products of Indivior plc

Indivior PLC maintains a monopoly position in opioid addiction therapy, bolstered by patents for Sublocade, which creates a sustainable barrier to entry for competitors. This advantage is quantified through net income per share, measuring the business's actual equity efficiency over the year; furthermore, an analysis of the rolling annual earnings per share allows for the determination of the issuer's capital stability during periods of market volatility.

Competitor analysis for Indivior PLC

COLL - Earnings per share for the last twelve months|Earnings per share for the trailing year CRON (thecronosgroup.com)|Canopy Growth Corporation (CGC) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months High Tide Inc|ACB (Aurora Cannabis, Inc.) - Net earnings per share (EPS TTM)|Achieve Life Sciences Inc (ACHV) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Skye Bioscience (SKYE)|anebulo.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) INCR (InterCure)|NTRB: Earnings per share for the last 12 months|Nasus Pharma, Ltd. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters IGC Pharma, Inc. IGC|MIRA (mirapharmaceuticals.com) - Net earnings per share for the last 12 months|FLGC (floragrowth.ca) - Earnings per share for the last twelve months|IMCC (IM Cannabis Corp) - Net earnings per share (EPS TTM)|Adial (ADIL) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Artelo Biosciences (ARTL)|ENSC - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Titan Pharmaceuticals, Inc. TTNP|Earnings per share for the trailing year GNLN|INM: Net earnings per share for the last 12 months|Earnings per share for the trailing year AKAN (Akanda Corp)|Enveric (ENVB) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months BGXX (Bright Green Corporation)|Earnings per share for the last twelve months Hempacco Co., Inc.